Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01407874 · ClinicalTrials.gov registry record · Phase 2

A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency

A Phase 2 study of Arthritis and Gout, sponsored by BioCryst Pharmaceuticals.

Completed
Registry status
Phase 2
Development phase
20
Enrollment target
10
Study locations

NCT01407874 is a Phase 2 study of Arthritis and Gout that has completed, run by BioCryst Pharmaceuticals. The registered enrollment target is 20 participants, below the 4,510-participant average among 48 other Arthritis trials with a reported enrollment target (100% lower). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01407874, a Phase 2 study of Arthritis and Gout, has completed, sponsored by BioCryst Pharmaceuticals.

COMPLETED
Registry status
Phase 2
Development phase
20 participants
Enrollment target
10
Study locations

Study Summary

To evaluate the overall safety and tolerability of ulodesine when combined with allopurinol in subjects with moderate renal insufficiency.

Conditions Studied

Arthritis Gout Renal Insufficiency Hyperuricemia Joint Disease

Interventions

  • DRUG Placebo
  • DRUG Ulodesine (BCX4208) 5 mg
  • DRUG Ulodesine (BCX4208) 10 mg

Study Locations (10)

Texas

  • - Dallas
  • - San Antonio

Alabama

  • - Mobile

Arizona

  • - Peoria

California

  • - Irvine

Florida

  • - Oldsmar

Hawaii

  • - Honolulu

Kansas

  • - Newton

Tennessee

  • - Knoxville

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-09
Est. Completion 2012-07
Phase Phase 2

Sponsor

BioCryst Pharmaceuticals

29 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01407874

The ClinicalTrials.gov registry entry for NCT01407874 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,510-participant average among 48 other Arthritis trials with a reported enrollment target (100% lower). The listed sponsor is BioCryst Pharmaceuticals, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Arthritis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT01407874 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Texas, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT01407874 about?

NCT01407874 is a clinical study titled "A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency". To evaluate the overall safety and tolerability of ulodesine when combined with allopurinol in subjects with moderate renal insufficiency.

What is the current status of trial NCT01407874?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2011-09. Estimated completion is 2012-07.

What conditions does trial NCT01407874 study?

This clinical trial studies the following conditions: Arthritis, Gout, Renal Insufficiency, Hyperuricemia, Joint Disease.

What interventions are being tested in trial NCT01407874?

The interventions under investigation include: Placebo (DRUG), Ulodesine (BCX4208) 5 mg (DRUG), Ulodesine (BCX4208) 10 mg (DRUG).

Who is sponsoring clinical trial NCT01407874?

This trial is sponsored by BioCryst Pharmaceuticals, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01407874 being conducted?

This trial has 10 study locations across Alabama, Arizona, California, Florida, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Arthritis

All registered trials for this condition

Gout

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.